GEODE CAPITAL MANAGEMENT, LLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$153,666
-4.6%
216,4310.0%0.00%
Q1 2023$161,067
+102490.4%
216,4310.0%0.00%
Q4 2022$157
-99.9%
216,431
-5.4%
0.00%
Q3 2022$221,000
-49.3%
228,7340.0%0.00%
Q2 2022$436,000
-77.9%
228,734
-42.4%
0.00%
Q1 2022$1,974,000
-37.4%
397,191
-4.9%
0.00%
Q4 2021$3,152,000
+5.0%
417,567
+9.8%
0.00%
Q3 2021$3,003,000
-38.5%
380,213
+8.0%
0.00%
-100.0%
Q2 2021$4,881,000
-21.0%
351,962
+19.2%
0.00%0.0%
Q1 2021$6,177,000
+103.3%
295,274
+61.4%
0.00%0.0%
Q4 2020$3,038,000
+14.2%
182,941
+16.8%
0.00%0.0%
Q3 2020$2,660,000
+22.6%
156,564
+19.8%
0.00%
Q2 2020$2,169,000
+88.3%
130,679
+31.3%
0.00%
Q1 2020$1,152,000
-55.5%
99,531
-43.1%
0.00%
Q4 2019$2,586,000
+366.8%
174,854
+330.4%
0.00%
Q3 2019$554,000
+21.2%
40,628
+15.6%
0.00%
Q2 2019$457,000
+315.5%
35,154
+200.2%
0.00%
Q1 2019$110,00011,7090.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$15,689,0007.73%
MPM ASSET MANAGEMENT LLC 3,131,388$15,563,0005.32%
MPM BioImpact LLC 3,196,707$15,888,0004.26%
ACUTA CAPITAL PARTNERS, LLC 497,500$2,473,0001.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 151,445$2,771,0000.62%
Orbimed Advisors 3,039,508$15,106,0000.24%
Artal Group S.A. 1,000,000$4,970,0000.21%
Cormorant Asset Management, LP 540,600$2,687,0000.21%
DAFNA Capital Management LLC 105,163$523,0000.14%
Ikarian Capital, LLC 117,009$582,0000.08%
View complete list of HARPOON THERAPEUTICS INC shareholders